Developer docs
API playgroundTry for free, no card

Search company profiles

Parathyroid Uk

Full company profile

uuid02lpy4e

Namestring
Parathyroid Uk
Legal namestring
Parathyroid UK
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Parathyroid UK is a UK-based non-profit patient support and advocacy organization founded in July 2005 by Liz Glenister (CEO) following her own experience with post-surgical hypoparathyroidism after thyroid cancer surgery in 1992. Originally named HPTH UK, it is the only organization in the UK and Ireland dedicated to improving the lives of people affected by parathyroid conditions, including hypoparathyroidism, hyperparathyroidism, and related disorders of post-surgical, genetic, autoimmune, congenital, and idiopathic origin. The organization serves approximately 2,000 members across the UK and Ireland, supported by a small team of 1-10 employees and a network of medical advisors.

Short descriptiontext

Parathyroid UK is a UK and Ireland non-profit founded in 2005 that provides information, peer support, and advocacy for nearly 2,000 patients living with parathyroid conditions, serving as the sole dedicated patient organization in its disease area.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersEast Grinstead, United Kingdom
HQ citystring
East Grinstead
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patient advocacy, rare disease support, health information services, patient education resources, parathyroid support
Industry1 code
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Other Similar Organizations (except Business, Professional, Labor, and Political Organizations)813990
SIC code2 codes
  • Services-Social Services8300
  • Services-Membership Organizations8600
Product category
Patient Advocacy Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Donations
TypeAffiliate Referral
Description

Parathyroid UK accepts donations from individuals, supporters, and industry partners to fund their operations and advocacy work.

parathyroiduk.org
2Shop/Merchandise
TypeHardware Sales
Description

The organization operates a shop selling merchandise and emergency ID items.

parathyroiduk.org
3Membership
TypeFreemium
Description

Free membership is offered to patients and caregivers, providing access to support groups, information, and resources.

parathyroiduk.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Free membership with access to support groups, helpline, and resources
ModelFreemiumBilling cadenceMonthly
Notes

No membership fee required. Donations welcome. Shop items available for purchase.

parathyroiduk.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Parathyroid UK is a non-profit patient support organization that provides information, peer support, and advocacy services for people affected by hypoparathyroidism, hyperparathyroidism, and related parathyroid conditions in the UK and Ireland. It operates a telephone helpline, private Facebook support groups, patient information leaflets, a self-help guide, clinical guidelines for healthcare professionals, and an annual World Hypopara Awareness Day reaching patients in over 30 countries. The organization also facilitates patient participation in clinical trials and campaigns for improved diagnosis, treatment, and care pathways.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Post-surgical hypoparathyroidism risk reduced from 27-30% to 7-10%
+2 more records
Product overview1 text field

Parathyroid UK is a patient support organization offering a unified portfolio of support services for people affected by parathyroid conditions. The core offering consists of peer support communities (Facebook groups), patient education materials (leaflets, self-help guides, videos, podcasts), clinical guidelines for healthcare professionals, and emergency ID items. These services are designed to work together to provide comprehensive support from diagnosis through ongoing management, supported by a telephone helpline and membership program.

Product and service1 record
1Patient Support Groups
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
1Amolyt Pharma
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-10-31
Description

Parathyroid UK partnered with Amolyt Pharma on the CALYPSO study testing eneboparatide, a new investigational PTH medication. Study centers in Norwich, Leicester, and Oxford were involved.

parathyroiduk.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Parathyroid UK worked with Ascendis Pharma on Yorvipath (palopegteriparatide), a new parathyroid hormone treatment. The MHRA approved Yorvipath in April 2024 for chronic hypoparathyroidism in adults. Parathyroid UK participated in NICE approval process as stakeholders.

3Sheffield University (Mr. Saba Balasubramanian)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Parathyroid UK worked closely with surgeon Saba Balasubramanian and his team at Sheffield University on the NIFTy trial studying near-infrared fluorescence imaging to reduce parathyroid damage during thyroid surgery.

parathyroiduk.org
Strategic tierMinorTypeGTM or Marketing Partner
Description

Parathyroid UK partnered with Takeda to provide helpful tips and hints for day-to-day living with hypoparathyroidism to support World Hypopara Day.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Patients may access Yorvipath via Individual Funding Request if their case warrants it. Consultant endocrinologist must apply to Ascendis Pharma.

Strategic tierCoreTypeOthers
Description

Parathyroid UK is affiliated with Society for Endocrinology as an Affiliated Patient Support Group, participating in SfE BES conferences and workshops.

Strategic tierCoreTypeOthers
Description

Parathyroid UK has affiliate status with ESE, with their information endorsed by the organization.

8BAETS (British Association of Endocrine and Thyroid Surgeons)
Strategic tierCoreTypeOthers
Description

BAETS endorses Parathyroid UK patient information. Parathyroid UK participates in BAETS annual meetings.

parathyroiduk.org
9British Thyroid Association
Strategic tierCoreTypeOthers
Description

British Thyroid Association endorses Parathyroid UK patient information materials.

parathyroiduk.org
Strategic tierMinorTypeOthers
Description

Parathyroid UK is a member of Rare Diseases UK, the national campaign for people with rare diseases.

Strategic tierMinorTypeOthers
Description

Parathyroid UK is a member of Genetic Alliance UK, the alliance of patient organizations supporting those affected by genetic conditions.

Strategic tierMinorTypeOthers
Description

Parathyroid UK is a member of National Voices, the leading coalition of health and social care charities in England.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Leading coalition of health and social care charities in England; Parathyroid UK is a member. Comparable as a peer in policy advocacy and collective representation across UK health charities.

TypeOthers
Description

National UK campaign coalition for people with rare diseases, of which Parathyroid UK is itself a member organization. Relevant as an ecosystem/umbrella peer — represents the collective advocacy layer Parathyroid UK plugs into for policy influence.

TypeOthers
Description

UK alliance of patient organizations supporting those with genetic conditions; Parathyroid UK is a member. Comparable as an enabling/coalition peer given shared focus on patient representation and policy advocacy for rare and genetic conditions.

4Addison's Disease Self-Help Group (ADSHG)
TypeDirect peer
Description

UK-based small patient support charity focused on a rare endocrine condition. Closely comparable operating model — helpline, peer support groups, GP-facing resources, and partnerships with SfE/ESE-affiliated medical advisors.

5Royal Osteoporosis Society (formerly National Osteoporosis Society)
TypeBroad incumbent
Description

Larger UK charity focused on a bone-density condition closely related to calcium/parathyroid metabolism. Comparable in mission framing around calcium homeostasis but operates at a meaningfully larger scale and broader scope.

6British Thyroid Foundation
TypeDirect peer
Description

UK patient charity for thyroid conditions, many of which (e.g., thyroidectomy) are clinically linked to parathyroid conditions. Same model: patient leaflets, support network, and engagement with endocrine surgery bodies including BAETS.

TypeOthers
Description

Commercial pharma partner that co-developed Yorvipath (palopegteriparatide), the first PTH-replacement therapy approved for chronic hypoparathyroidism in adults (MHRA, April 2024). Relevant as an ecosystem peer given Parathyroid UK's role in advocacy and NICE stakeholder engagement for the product.

TypeOthers
Description

UK professional endocrinology society that affiliates Parathyroid UK as a patient support group. Relevant as a peer relationship representing the medical-professional infrastructure the charity depends on for credibility and conference access.

9Thyroid UK
TypeDirect peer
Description

UK patient-focused charity covering thyroid disorders, with substantial overlap in patient population (post-thyroid surgery patients are at risk of parathyroid injury). Operates with similar awareness, support, and information dissemination model.

TypeDirect peer
Description

UK-based endocrine patient support charity. Directly comparable as a small, disease-specific endocrine patient advocacy organization offering helpline, peer support, patient information leaflets, and medical-professional resources in an adjacent endocrine niche.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Parathyroid Uk

Patient Advocacy Servicesparathyroiduk.org

Parathyroid UK is a UK and Ireland non-profit founded in 2005 that provides information, peer support, and advocacy for nearly 2,000 patients living with parathyroid conditions, serving as the sole dedicated patient organization in its disease area.

What Parathyroid Uk does

Parathyroid UK is a UK-based non-profit patient support and advocacy organization founded in July 2005 by Liz Glenister (CEO) following her own experience with post-surgical hypoparathyroidism after thyroid cancer surgery in 1992. Originally named HPTH UK, it is the only organization in the UK and Ireland dedicated to improving the lives of people affected by parathyroid conditions, including hypoparathyroidism, hyperparathyroidism, and related disorders of post-surgical, genetic, autoimmune, congenital, and idiopathic origin. The organization serves approximately 2,000 members across the UK and Ireland, supported by a small team of 1-10 employees and a network of medical advisors.

Parathyroid Uk firmographics

Firmographics
Name
Parathyroid Uk
Legal name
Parathyroid UK
Website
https://parathyroiduk.org
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1–10 employees
Short description
Parathyroid UK is a UK and Ireland non-profit founded in 2005 that provides information, peer support, and advocacy for nearly 2,000 patients living with parathyroid conditions, serving as the sole dedicated patient organization in its disease area.
Ownership category
akta.pro rank

Parathyroid Uk industry classification

Industry
Product category
Patient Advocacy Services
NAICS
Voluntary Health Organizations (813212), Other Similar Organizations (except Business, Professional, Labor, and Political Organizations) (813990)
SIC
Services-Social Services (8300), Services-Membership Organizations (8600)
akta.pro industry
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)

Keywords

  • Patient advocacy
  • Rare disease support
  • Health information services
  • Patient education resources
  • Parathyroid support

Where Parathyroid Uk is headquartered

Location

Headquarters

HQ city
East Grinstead
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Parathyroid Uk business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Donations: Parathyroid UK accepts donations from individuals, supporters, and industry partners to fund their operations and advocacy work.
  2. Shop/Merchandise: The organization operates a shop selling merchandise and emergency ID items.
  3. Membership: Free membership is offered to patients and caregivers, providing access to support groups, information, and resources.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree membership with access to support groups, helpline, and resources

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Parathyroid Uk product offering

Product offering

Core offering

Parathyroid UK is a non-profit patient support organization that provides information, peer support, and advocacy services for people affected by hypoparathyroidism, hyperparathyroidism, and related parathyroid conditions in the UK and Ireland. It operates a telephone helpline, private Facebook support groups, patient information leaflets, a self-help guide, clinical guidelines for healthcare professionals, and an annual World Hypopara Awareness Day reaching patients in over 30 countries. The organization also facilitates patient participation in clinical trials and campaigns for improved diagnosis, treatment, and care pathways.

Product overview

Parathyroid UK is a patient support organization offering a unified portfolio of support services for people affected by parathyroid conditions. The core offering consists of peer support communities (Facebook groups), patient education materials (leaflets, self-help guides, videos, podcasts), clinical guidelines for healthcare professionals, and emergency ID items. These services are designed to work together to provide comprehensive support from diagnosis through ongoing management, supported by a telephone helpline and membership program.

Differentiator

Problem solved

Functional benefit

Products and services

  • Patient Support Groups

Quantifiable outcome

  • Post-surgical hypoparathyroidism risk reduced from 27-30% to 7-10%
  • +2 more outcomes

Companies that use Parathyroid Uk

Customer profile

Named customers11 records

Segments5 records

Ideal customer profiles2 records

Parathyroid Uk technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Parathyroid Uk partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and minor.

  • Amolyt PharmacoreStrategic or Co-development Partner · 31 October 2023Parathyroid UK partnered with Amolyt Pharma on the CALYPSO study testing eneboparatide, a new investigational PTH medication. Study centers in Norwich, Leicester, and Oxford were involved.
  • Ascendis PharmacoreStrategic or Co-development PartnerParathyroid UK worked with Ascendis Pharma on Yorvipath (palopegteriparatide), a new parathyroid hormone treatment. The MHRA approved Yorvipath in April 2024 for chronic hypoparathyroidism in adults. Parathyroid UK participated in NICE approval process as stakeholders.
  • Sheffield University (Mr. Saba Balasubramanian)coreStrategic or Co-development PartnerParathyroid UK worked closely with surgeon Saba Balasubramanian and his team at Sheffield University on the NIFTy trial studying near-infrared fluorescence imaging to reduce parathyroid damage during thyroid surgery.
  • TakedaminorGTM or Marketing PartnerParathyroid UK partnered with Takeda to provide helpful tips and hints for day-to-day living with hypoparathyroidism to support World Hypopara Day.
  • Ascendis Pharma (Individual Funding Request)minorGTM or Marketing PartnerPatients may access Yorvipath via Individual Funding Request if their case warrants it. Consultant endocrinologist must apply to Ascendis Pharma.
  • Society for Endocrinology (SfE)coreOthersParathyroid UK is affiliated with Society for Endocrinology as an Affiliated Patient Support Group, participating in SfE BES conferences and workshops.
  • European Society of Endocrinology (ESE)coreOthersParathyroid UK has affiliate status with ESE, with their information endorsed by the organization.
  • BAETS (British Association of Endocrine and Thyroid Surgeons)coreOthersBAETS endorses Parathyroid UK patient information. Parathyroid UK participates in BAETS annual meetings.
  • British Thyroid AssociationcoreOthersBritish Thyroid Association endorses Parathyroid UK patient information materials.
  • Rare Diseases UKminorOthersParathyroid UK is a member of Rare Diseases UK, the national campaign for people with rare diseases.
  • Genetic Alliance UKminorOthersParathyroid UK is a member of Genetic Alliance UK, the alliance of patient organizations supporting those affected by genetic conditions.
  • National VoicesminorOthersParathyroid UK is a member of National Voices, the leading coalition of health and social care charities in England.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Parathyroid Uk competitors and assessment

Company assessment

Others

  • National Voices: Leading coalition of health and social care charities in England; Parathyroid UK is a member. Comparable as a peer in policy advocacy and collective representation across UK health charities.
  • Rare Diseases UK: National UK campaign coalition for people with rare diseases, of which Parathyroid UK is itself a member organization. Relevant as an ecosystem/umbrella peer — represents the collective advocacy layer Parathyroid UK plugs into for policy influence.
  • Genetic Alliance UK: UK alliance of patient organizations supporting those with genetic conditions; Parathyroid UK is a member. Comparable as an enabling/coalition peer given shared focus on patient representation and policy advocacy for rare and genetic conditions.
  • Ascendis Pharma: Commercial pharma partner that co-developed Yorvipath (palopegteriparatide), the first PTH-replacement therapy approved for chronic hypoparathyroidism in adults (MHRA, April 2024). Relevant as an ecosystem peer given Parathyroid UK's role in advocacy and NICE stakeholder engagement for the product.
  • Society for Endocrinology (SfE): UK professional endocrinology society that affiliates Parathyroid UK as a patient support group. Relevant as a peer relationship representing the medical-professional infrastructure the charity depends on for credibility and conference access.

Direct peers

  • Addison's Disease Self-Help Group (ADSHG): UK-based small patient support charity focused on a rare endocrine condition. Closely comparable operating model — helpline, peer support groups, GP-facing resources, and partnerships with SfE/ESE-affiliated medical advisors.
  • British Thyroid Foundation: UK patient charity for thyroid conditions, many of which (e.g., thyroidectomy) are clinically linked to parathyroid conditions. Same model: patient leaflets, support network, and engagement with endocrine surgery bodies including BAETS.
  • Thyroid UK: UK patient-focused charity covering thyroid disorders, with substantial overlap in patient population (post-thyroid surgery patients are at risk of parathyroid injury). Operates with similar awareness, support, and information dissemination model.
  • The Pituitary Foundation: UK-based endocrine patient support charity. Directly comparable as a small, disease-specific endocrine patient advocacy organization offering helpline, peer support, patient information leaflets, and medical-professional resources in an adjacent endocrine niche.

Broad incumbents

  • Royal Osteoporosis Society (formerly National Osteoporosis Society): Larger UK charity focused on a bone-density condition closely related to calcium/parathyroid metabolism. Comparable in mission framing around calcium homeostasis but operates at a meaningfully larger scale and broader scope.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Parathyroid Uk social profiles

Digital presence

Parathyroid Uk financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Parathyroid Uk leadership team

Management profile

Number of profiles

Profiles1 record

Parathyroid Uk funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Parathyroid Uk M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parathyroid Uk

What does Parathyroid Uk do?

Parathyroid UK is a non-profit patient support organization that provides information, peer support, and advocacy services for people affected by hypoparathyroidism, hyperparathyroidism, and related parathyroid conditions in the UK and Ireland. It operates a telephone helpline, private Facebook support groups, patient information leaflets, a self-help guide, clinical guidelines for healthcare professionals, and an annual World Hypopara Awareness Day reaching patients in over 30 countries. The organization also facilitates patient participation in clinical trials and campaigns for improved diagnosis, treatment, and care pathways.

Is Parathyroid Uk a public or private company?

Parathyroid Uk is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Parathyroid Uk founded?

Parathyroid Uk was founded in 2005. It employs 1 to 10 people.

Where is Parathyroid Uk based?

Parathyroid Uk is headquartered in East Grinstead, United Kingdom, in the Europe region.

How does Parathyroid Uk make money?

Three revenue lines are on record. Donations are the primary driver. The others are shop/Merchandise and membership.

Who are Parathyroid Uk's main competitors?

Others on record are National Voices, Rare Diseases UK, Genetic Alliance UK, Ascendis Pharma and Society for Endocrinology (SfE). Direct peers are Addison's Disease Self-Help Group (ADSHG), British Thyroid Foundation, Thyroid UK and The Pituitary Foundation. Royal Osteoporosis Society (formerly National Osteoporosis Society) is listed as a broad incumbent.

Does Parathyroid Uk have an API?

No public API is recorded for Parathyroid Uk.

What industry is Parathyroid Uk in?

Parathyroid Uk's product category is Patient Advocacy Services. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales